First Time Loading...

Integral Diagnostics Ltd
ASX:IDX

Watchlist Manager
Integral Diagnostics Ltd Logo
Integral Diagnostics Ltd
ASX:IDX
Watchlist
Price: 2.47 AUD -1.59% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one IDX stock under the Base Case scenario is 6.61 AUD. Compared to the current market price of 2.47 AUD, Integral Diagnostics Ltd is Undervalued by 63%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDX Relative Value
Base Case
6.61 AUD
Undervaluation 63%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
90
vs Industry
62
Median 3Y
1.9
Median 5Y
2.1
Industry
2.4
Forward
1.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
23
Median 3Y
31.6
Median 5Y
29.7
Industry
23.2
Forward
33
More Details
9.3
P/OCF
P/OCF
Price to OCF
9.3
vs History
87
vs Industry
38
Median 3Y
14.3
Median 5Y
14.3
Industry
15.5
More Details
34.2
P/FCFE
P/FCFE
Price to FCFE
34.2
vs History
23
vs Industry
17
Median 3Y
23.2
Median 5Y
19
Industry
23.5
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
71
vs Industry
44
Median 3Y
2
Median 5Y
3
Industry
2.2
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
90
vs Industry
49
Median 3Y
2.6
Median 5Y
2.7
Industry
2.5
Forward
1.9
More Details
2.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.1
vs History
90
vs Industry
69
Median 3Y
2.7
Median 5Y
2.9
Industry
5.2
More Details
21.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.3
vs History
41
vs Industry
15
Median 3Y
22.3
Median 5Y
20.6
Industry
12.5
Forward
9.8
More Details
21.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.3
vs History
41
vs Industry
22
Median 3Y
22.3
Median 5Y
20.6
Industry
17.2
Forward
21.8
More Details
14.5
EV/OCF
EV/OCF
Enterprise Value to OCF
14.5
vs History
79
vs Industry
29
Median 3Y
17.6
Median 5Y
17.9
Industry
15.1
More Details
45.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
45.4
vs History
38
vs Industry
11
Median 3Y
42.8
Median 5Y
39.8
Industry
19.7
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
74
vs Industry
52
Median 3Y
1.4
Median 5Y
1.7
Industry
2
More Details

Multiples Across Competitors

IDX Competitors Multiples
Integral Diagnostics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Integral Diagnostics Ltd
ASX:IDX
576.6m AUD 1.3 -10 21.3 21.3
US
Cigna Group
XMUN:CGN
96.6B EUR 0.5 20.1 10.3 13.8
US
Cigna Corp
NYSE:CI
103.7B USD 0.5 20.1 10.3 13.8
US
CVS Health Corp
NYSE:CVS
86.5B USD 0.2 10.4 8.9 8.9
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR 1.1 44.4 10.4 24.6
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD 1.4 38.6 11.8 17.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.3B EUR 0.7 -25.8 9.9 22.2
US
Quest Diagnostics Inc
NYSE:DGX
14.9B USD 1.6 17.7 10.6 14.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 22 6.7 15.9
US
DaVita Inc
NYSE:DVA
11.9B USD 1 17.1 8.4 12.3
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
IDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDX stock valuation using valuation multiples.
Wall Street Estimates
IDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.